Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | HTR1B | P28222 | 1/20 | 0.38 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL367380 | 0.94 | KDM1A (0.46) | KDM1ADRD3POLBHSD17B3PARP1 | |
| SCHEMBL7275357 | 0.89 | ALDH1A1 (0.53) | KDM1ADRD3POLBALDH1A1SMYD3 | |
| SCHEMBL8881136 | 0.84 | KDM4E (0.45) | ALDH1A1 | |
| SCHEMBL12152999 | 0.82 | PARP1 (0.43) | KDM1ADRD3HSD17B3PARP1PARP15 | |
| SCHEMBL2786999 | 0.81 | SIRT1 (0.52) | HSD17B3OPRK1 | |
| SCHEMBL10197703 | 0.79 | PARP1 (0.46) | KDM1APARP1PARP15PARP10 | |
| SCHEMBL4794024 | 0.78 | DRD3 (0.42) | DRD3OPRK1 | |
| SCHEMBL2785677 | 0.78 | OPRK1 (0.37) | OPRK1ALDH1A1 | |
| SCHEMBL346421 | 0.78 | PLAU (0.52) | ALDH1A1 | |
| SCHEMBL30711622 | 0.78 | PLAU (0.52) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10035640-B2 | Oxygen-absorbing multilayer body, oxygen-absorbing container, oxygen-absorbing airtight container, oxygen-absorbing push-through pack, and storage method using same | MITSUBISHI HAS CHEMICAL COMPANY, INC. (JP) | 2018-07-31 | — | — | US | disclosed |
| US-20120015943-A1 | SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF | MILLENNIUM PHARMACUTICALS, INC. (US) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015943-A1 | SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF | HDAC6, HDAC1, HDAC2 | KDM1A 82/4885DRD3 2383/4885POLB 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.